Page last updated: 2024-08-23

selegiline and Sleep Initiation and Maintenance Disorders

selegiline has been researched along with Sleep Initiation and Maintenance Disorders in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (25.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	4 (50.00)	29.6817
2010's	1 (12.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jang, S; Jung, S; Nelson, JC; Pae, CU; Patkar, AA; Portland, KB	1
Csoka, AB; Shipko, S	1
Feiger, AD; Rickels, K; Robinson, DS; Rynn, MA; Zimbroff, DL	1
Frampton, JE; Plosker, GL	1
Amsterdam, JD; Robinson, DS	1
Lavie, P; Wajsbort, J; Youdim, MB	1
Chouinard, S; Fahn, S	1
Birkmayer, W	1

Reviews

2 review(s) available for selegiline and Sleep Initiation and Maintenance Disorders

Article	Year
Efficacy and safety of selegiline transdermal system (STS) for the atypical subtype of major depressive disorder: pooled analysis of 5 short-term, placebo-controlled trials. CNS spectrums, 2014, Volume: 19, Issue:4 Topics: Administration, Cutaneous; Adult; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Psychophysiologic Disorders; Randomized Controlled Trials as Topic; Selegiline; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Weight Loss	2014
The selegiline transdermal system in major depressive disorder: a systematic review of safety and tolerability. Journal of affective disorders, 2008, Volume: 105, Issue:1-3 Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Humans; Hypertension; Hypotension, Orthostatic; Male; Middle Aged; Monoamine Oxidase Inhibitors; Selegiline; Serotonin Syndrome; Sexual Dysfunction, Physiological; Sleep Initiation and Maintenance Disorders	2008

Article

Year

Efficacy and safety of selegiline transdermal system (STS) for the atypical subtype of major depressive disorder: pooled analysis of 5 short-term, placebo-controlled trials.

CNS spectrums, 2014, Volume: 19, Issue:4

Topics: Administration, Cutaneous; Adult; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Psychophysiologic Disorders; Randomized Controlled Trials as Topic; Selegiline; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Weight Loss

2014

The selegiline transdermal system in major depressive disorder: a systematic review of safety and tolerability.

Journal of affective disorders, 2008, Volume: 105, Issue:1-3

Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Humans; Hypertension; Hypotension, Orthostatic; Male; Middle Aged; Monoamine Oxidase Inhibitors; Selegiline; Serotonin Syndrome; Sexual Dysfunction, Physiological; Sleep Initiation and Maintenance Disorders

2008

Trials

2 trial(s) available for selegiline and Sleep Initiation and Maintenance Disorders

Article	Year
Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial. The Journal of clinical psychiatry, 2006, Volume: 67, Issue:9 Topics: Administration, Cutaneous; Adult; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Monoamine Oxidase Inhibitors; Personality Inventory; Placebos; Psychiatric Status Rating Scales; Selegiline; Sleep Initiation and Maintenance Disorders; Treatment Outcome	2006
Experience with tranylcypromine in early Parkinson's disease. Journal of neural transmission. Supplementum, 1998, Volume: 52 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Depression; Erectile Dysfunction; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline; Sleep Initiation and Maintenance Disorders; Time Factors; Tranylcypromine; Tyramine	1998

Article

Year

Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial.

The Journal of clinical psychiatry, 2006, Volume: 67, Issue:9

Topics: Administration, Cutaneous; Adult; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Monoamine Oxidase Inhibitors; Personality Inventory; Placebos; Psychiatric Status Rating Scales; Selegiline; Sleep Initiation and Maintenance Disorders; Treatment Outcome

2006

Experience with tranylcypromine in early Parkinson's disease.

Journal of neural transmission. Supplementum, 1998, Volume: 52

Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Depression; Erectile Dysfunction; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline; Sleep Initiation and Maintenance Disorders; Time Factors; Tranylcypromine; Tyramine

1998

Other Studies

4 other study(ies) available for selegiline and Sleep Initiation and Maintenance Disorders

Article	Year
Persistent sexual side effects after SSRI discontinuation. Psychotherapy and psychosomatics, 2006, Volume: 75, Issue:3 Topics: Adult; Androgens; Anxiety; Bupropion; Cabergoline; Citalopram; Depressive Disorder; Dopamine Agonists; Dopamine Uptake Inhibitors; Ergolines; Female; Fluoxetine; Humans; Male; Monoamine Oxidase Inhibitors; Piperazines; Plants, Medicinal; Purines; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sleep Initiation and Maintenance Disorders; Sulfones; Testosterone; Time Factors; Treatment Outcome; Vasodilator Agents	2006
Selegiline transdermal system in major depressive disorder: profile report. CNS drugs, 2007, Volume: 21, Issue:6 Topics: Administration, Cutaneous; Area Under Curve; Depressive Disorder, Major; Diarrhea; Drug Administration Schedule; Half-Life; Headache; Humans; Monoamine Oxidase Inhibitors; Selegiline; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Xerostomia	2007
Deprenyl does not cause insomnia in parkinsonian patients. Communications in psychopharmacology, 1980, Volume: 4, Issue:4 Topics: Aged; Electroencephalography; Humans; Middle Aged; Parkinson Disease; Phenethylamines; Selegiline; Sleep; Sleep Initiation and Maintenance Disorders	1980
[Therapeutic strategies and tactics in parkinsonism]. Wiener medizinische Wochenschrift (1946), 1986, Aug-31, Volume: 136, Issue:15-16 Topics: Amantadine; Antidepressive Agents; Antiparkinson Agents; Benserazide; Carbidopa; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Motor Skills; Parkinson Disease; Selegiline; Sleep Initiation and Maintenance Disorders	1986